Harvard Bioscience, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold HBIO, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
11
Funds holding
$720175
Total value held
Flat
4 added/new · 4 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $380280 | 61834 | -392 | -0.63% |
| 2 | Ubs Group Ag | $108123 | 17581 | +17581 | NEW BUY |
| 3 | State Street Corp | $91832 | 14932 | — | Held |
| 4 | Goldman Sachs Group Inc | $65541 | 10657 | +10657 | NEW BUY |
| 5 | Bank Of New York Mellon Corp | $62915 | 10230 | — | Held |
| 6 | Morgan Stanley | $10006 | 1627 | -1 | -0.06% |
| 7 | Jpmorgan Chase & Co | $1194 | 195 | -4268 | -95.63% |
| 8 | Barclays Plc | $160 | 26 | +26 | NEW BUY |
| 9 | Pnc Financial Services Group, Inc. | $86 | 14 | — | Held |
| 10 | Amalgamated Financial Corp. | $38 | 6198 | +6198 | NEW BUY |
| 11 | Royal Bank Of Canada | $0 | 15 | -840 | -98.25% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.